- Home
- HSAI vs SRRK Comparison
HSAI vs SRRK Comparison
Compare HSAI & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSAI
- SRRK
- Stock Information
- Founded
- HSAI 2014
- SRRK 2012
- Country
- HSAI China
- SRRK United States
- Employees
- HSAI N/A
- SRRK N/A
- Industry
- HSAI
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HSAI
- SRRK Health Care
- Exchange
- HSAI Nasdaq
- SRRK Nasdaq
- Market Cap
- HSAI 2.8B
- SRRK 3.2B
- IPO Year
- HSAI 2023
- SRRK 2018
- Fundamental
- Price
- HSAI $22.50
- SRRK $37.15
- Analyst Decision
- HSAI Strong Buy
- SRRK Strong Buy
- Analyst Count
- HSAI 1
- SRRK 6
- Target Price
- HSAI $29.30
- SRRK $42.17
- AVG Volume (30 Days)
- HSAI 3.3M
- SRRK 1.4M
- Earning Date
- HSAI 08-18-2025
- SRRK 08-07-2025
- Dividend Yield
- HSAI N/A
- SRRK N/A
- EPS Growth
- HSAI N/A
- SRRK N/A
- EPS
- HSAI N/A
- SRRK N/A
- Revenue
- HSAI $309,148,901.00
- SRRK N/A
- Revenue This Year
- HSAI $62.24
- SRRK N/A
- Revenue Next Year
- HSAI $44.69
- SRRK $502.60
- P/E Ratio
- HSAI N/A
- SRRK N/A
- Revenue Growth
- HSAI 24.20
- SRRK N/A
- 52 Week Low
- HSAI $3.52
- SRRK $6.76
- 52 Week High
- HSAI $24.18
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- HSAI 60.71
- SRRK 55.02
- Support Level
- HSAI $20.36
- SRRK $33.60
- Resistance Level
- HSAI $23.38
- SRRK $35.90
- Average True Range (ATR)
- HSAI 1.56
- SRRK 2.09
- MACD
- HSAI 0.21
- SRRK -0.04
- Stochastic Oscillator
- HSAI 90.05
- SRRK 67.85
About HSAI Hesai Group each ADS represents one Class B ordinary share
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.